Fmr Llc

13F Holdings History for Stoke Therapeutics, Inc. - Common Stock, $0.0001 par value per share (STOK)

Symbol: STOK on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Ownership: 6.87M shares
Security Ownership: 12.5%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

2025-11-05 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.87M shares of Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK). This represents 12.5% percent ownership of the company. In their previous filing dated 2025-08-06, FMR LLC had reported owning 7.41M shares, indicating a decrease of -7.39% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	12.5%	-7.86%	$161M	6.87M	-547,925	-7.39%	$23.50	13G/A	9/30/2025	5 Nov 2025 11:49:28
FMR LLC	13.6%	+26.4%	$66.2M	7.41M	+1,553,971	+26.5%	$8.93	13G/A	6/30/2025	6 Aug 2025 12:14:18
FMR LLC	10.7%		$52.3M	5.86M			$8.93	13G	5/30/2025	6 Jun 2025 10:03:48

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.01%	0%	$161M	6.87M	-547,925	-7.39%	$23.50	Q3 2025
6/30/2025	0%	+0%	$84.1M	7.41M	+4,871,045	+192%	$11.35	Q2 2025
3/31/2025	0%	+0%	$16.9M	2.54M	+2,376,741	+1400%	$6.65	Q1 2025
12/31/2024	0%	0%	$1.82M	165K	-157,753	-48.8%	$11.03	Q4 2024
9/30/2024	0%	0%	$3.97M	323K	-75,070	-18.9%	$12.29	Q3 2024
6/30/2024	0%	+0%	$5.38M	398K	+22,538	+6%	$13.51	Q2 2024
3/31/2024	0%	+0%	$5.07M	375K	+370,481	+7410%	$13.50	Q1 2024
12/31/2023	0%	+0%	$26.3K	5K	+1,272	+34.1%	$5.26	Q4 2023
9/30/2023	0%	0%	$14.7K	3.73K	-2,321,757	-99.8%	$3.94	Q3 2023
6/30/2023	0%	+0%	$24.7M	2.33M	+357,274	+18.2%	$10.63	Q2 2023
3/31/2023	0%	0%	$16.4M	1.97M	-1,066,438	-35.1%	$8.33	Q1 2023
12/31/2022	0%	0%	$28M	3.03M	-147,854	-4.65%	$9.23	Q4 2022
9/30/2022	0%	+0%	$40.9M	3.18M	+217,516	+7.34%	$12.84	Q3 2022
6/30/2022	0%	+0%	$39.2M	2.96M	+189,406	+6.82%	$13.21	Q2 2022
3/31/2022	0%	+0%	$58.4M	2.78M	+220,784	+8.64%	$21.05	Q1 2022
12/31/2021	0%	+0%	$61.3M	2.55M	+101,929	+4.16%	$23.99	Q4 2021
9/30/2021	0%	+0%	$62.4M	2.45M	+321,417	+15.1%	$25.44	Q3 2021
6/30/2021	0.01%	0%	$71.7M	2.13M	-746,115	-25.9%	$33.66	Q2 2021
3/31/2021	0.01%	0%	$112M	2.88M	-723,409	-20.1%	$38.84	Q1 2021
12/31/2020	0.02%	+0.01%	$223M	3.6M	+1,659,095	+85.4%	$61.93	Q4 2020
9/30/2020	0.01%	+0%	$65M	1.94M	+1,170,014	+152%	$33.49	Q3 2020
6/30/2020	0%	+0%	$18.4M	772K	+305,519	+65.5%	$23.83	Q2 2020
3/31/2020	0%	0%	$10.7M	466K	-88,050	-15.9%	$22.90	Q1 2020
12/31/2019	0%	+0%	$15.7M	554K	+111,384	+25.1%	$28.32	Q4 2019
9/30/2019	0%	0%	$9.52M	443K	-206,987	-31.8%	$21.49	Q3 2019
6/30/2019	0%	+0%	$19M	650K	+650,000	NEW	$29.17	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.